USPTO

iX Biopharma secures Israel patent for WaferiX - THE EDGE SINGAPORE

Company in the news

iX Biopharma secures Israel patent for WaferiX

iX Biopharma says its intellectual property rights for its sublingual wafer technology is now secured in five continents.
×